Jiaying Pharmaceutical announced that Orient Securities, the shareholder of the company, currently holds 57.223 million shares of the company, accounting for 11.28% of the company's total share capital. It plans to reduce its holdings of the company's shares by 5.0751 million shares through centralized bidding within three months after 15 trading days from the date of the announcement of the reduction plan, that is, no more than 1% of the company's total share capital.

Jiaying Pharmaceutical announced that Orient Securities, the shareholder of the company, currently holds 57.223 million shares of the company, accounting for 11.28% of the company's total share capital. It plans to reduce its holdings of the company's shares by 5.0751 million shares through centralized bidding within three months after 15 trading days from the date of the announcement of the reduction plan, that is, no more than 1% of the company's total share capital.